Pharmafile Logo
Pharmafocus logo
Advanced Search
Shire image

Shire lifted by rare disease approvals

January 26, 2015
Sales and Marketing HGT-2310, Hunter syndrome, SHP609, Shire, fast track, idursulfase-IT, rare disease

Shire’s investigational drug for a rare neurological disease has been accepted into the FDA’s fast-track approval process. The drug, SHP609, …

News
Xarelto image

NICE recommends Bayer heart attack drug

January 26, 2015
Sales and Marketing ACS, Bayer, J&J, JJ, NICE, Xarelto, q4, rivaroxaban

NICE has recommended Xarelto in final draft guidance as an option for preventing blood clots in people who have had …

News
Novartis image

Novartis earns EMA and FDA nods for Jakavi and Bexsero

January 26, 2015
Sales and Marketing Bexsero, Cancer, EU, FDA, Jakavi, Novartis, US, meningitis, ruxolitinib

Novartis has secured the regulatory go-ahead for two of its drugs, after the EMA recommended Jakavi for a rare blood …

News
screen_shot_2015-01-26_at_07

Working Life: NHS England pharma officer Dr Bruce Warner

January 26, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS England, Working Life, bruce warner, pharma officer

 How did you find your way into your current role? I have had a very eclectic career for a pharmacist …

Feature
lynne_bulger

Cipher appoints vice president and promotes two

January 26, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Linda Angaritis, Peter Weiler, cipher, lynne bulgar

Cipher Pharmaceuticals has appointed Lynne Bulger as vice president of its medical and clinical affairs whilst also promoting Peter Weiler …

Appointment
GSK image

GSK launches Ebola Phase III trial in Liberia

January 23, 2015
Research and Development, Sales and Marketing Africa, Ebola, GSK, US National Institutes of Health, WHO, Wellcome Trust, liberia, newlink

A shipment of GSK’s potential vaccine against the Ebola virus disease is on its way to Liberia ready to be …

News
Tattoo image

Needle-free device shows potential in diabetes

January 23, 2015
Medical Communications, Sales and Marketing Cygnus, University of California, diabetes, tattoo

A ‘tattoo-like’ ultra-thin sensor that sits on the skin has been developed that could help patients monitor their blood glucose …

News
gad_berdugo_

Immune Pharmaceuticals appoints three

January 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Immune Pharmaceuticals, cameron durrant, elliot maza, gad berdugo

US antibody development firm Immune Pharmaceuticals has appointed Gad Berdugo (pictured) as its executive VP and chief financial officer, and …

Appointment
Apple image

FDA to start regulating health wearables

January 22, 2015
Medical Communications, Sales and Marketing Apple, FDA, Samsung, digital, wearables

Any firms making exaggerated health claims of wearable devices face marketplace disappointment following new FDA guidelines. The FDA has released …

News
Genzyme image

Sanofi Gaucher drug approved in Europe

January 22, 2015
Sales and Marketing Cerdelga, Cerezyme, Gaucher, Sanofi, eliglustat, imiglucerase

The European Commission has approved Sanofi-owned Genzyme’s Cerdelga for the treatment of Gaucher disease Type 1.Designed for a condition that …

News
Novartis image

Novartis gets FDA approval for psoriasis drug

January 22, 2015
Sales and Marketing Cosentyx, European Commission, FDA, Novartis, Secukinumab, psoriasis

The US Food and Drug Administration (FDA) has shown Novartis’ skin condition drug Cosentyx the green light to treat patients …

News
T cell image

UK makes £30m investment in T-Cell cancer therapy

January 22, 2015
Research and Development, Sales and Marketing Autolus, Cancer, London, T cell, UK, government, oncology, syncona

The UK is making a £30 million R&D investment into a promising new type of cancer treatment and is to …

News
EMA image

EMA launches consultation on clinical trials

January 22, 2015
Research and Development, Sales and Marketing EFPIA, EMA, EU, Europe, Goldacre, alltrials, transparency

The European Medicines Agency has invited pharma to comment on its proposals to ramp up transparency in the industry and …

News

New chief executive for AiCuris

January 22, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, Holger Zimmermann, Rübsamen-Schaeff

Founded in 2006 as a spin-off from Bayer, AiCuris has found a new chief executive as Helga Rübsamen-Schaeff steps aside …

Appointment
J&J image

Olysio and Xarelto boost J&J’s Q4

January 21, 2015
Sales and Marketing J&J, JJ, Janssen, NICE, Remicade, Velcade, Xarelto, financials, hep C, olysio, q4, quarter four

Johnson & Johnson earned a 10% increase in worldwide sales of its drugs in the last quarter of 2014 compared …

News

Gilead and Strides partner in HIV

January 21, 2015
Research and Development, Sales and Marketing Cipla, FDA, Gilead, HIV, Ranbaxy, Tenofovir Alafenamide, WHO, strides, taf

Gilead is partnering with India-based pharma firm Strides Arcolab in a licensing agreement to manufacture and distribute an HIV treatment …

News
UCB image

UCB epilepsy drug reaches regulatory bodies

January 21, 2015
Research and Development, Sales and Marketing EMA, FDA, UCB, brivaracetam, epilepsy

UCB has established regulatory milestones for its investigational antiepileptic drug brivaracetam in Europe and the US. The Food and Drug …

News

Biotec Services International, a PCI company, Completes First Phase of EU Clinical Supplies Facility Expansion

January 21, 2015

12 December 2014, Bridgend, UK. Biotec Services International has completed validation of their latest clinical supply facility expansion. The specification …

News
Press release
Giovanni Caforio image

BMS names operating officer as new chief executive

January 21, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Giovanni Caforio, Lamberto Andreotti, Yervoy, opdivo

Bristol-Myers Squibb’s chief operating officer Giovanni Caforio will be stepping in to Lamberto Andreotti’s shoes as chief executive from May …

News
hingge_hu

Tauriga Sciences adds venture capitalist

January 21, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hingge Hsu, tauriga sciences

US life sciences firm Tauriga Sciences has appointed Dr Hingge Hsu to its board of directors. Hsu was recently a …

Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026